Filter Results :

Your search for therapies returned 71 reports

Sort by


Alzheimer's Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies

01 Mar 2016  |  Published by:  GBI Research
SummaryAlzheimer’s Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. Symptoms typically begin to first occur in patients in their mid-sixties, appearing in varying stages. The pathologica...

$ 4,995.00

Read More

Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

11 Feb 2016  |  Published by:  GBI Research
SummaryParkinson's Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is associated with old age, and characterized by the loss of neurons in the substantia nigra region of the brain. The global Parkinson's Disease (PD) prevalence was...

$ 4,995.00

Read More

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

09 Jan 2016  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. It develops vitrogro, which is a ...

$ 300.00

Read More

Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

01 Jan 2016  |  Published by:  GBI Research
SummaryDiabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these. This chronic hyperglycemia is associated with long-term damage, dysfunction and fa...

$ 4,995.00

Read More

Targeted Therapies In Asthma: KOL Insight

01 Jan 2016  |  Published by:  FirstWord
Competition heating up as developers struggle to differentiate pipeline asthma antibodies Innovative monoclonal antibodies are breathing new life into the treatment of severe asthma. But with many of them targeting similar populations and providing similar benefits, finding a competitive ed...

$ 7,900.00

Read More

Biotie Therapies Corp. - Product Pipeline Review - 2015

30 Dec 2015  |  Published by:  Global Markets Direct
Summary‘Biotie Therapies Corp. - Product Pipeline Review - 2015’, provides an overview of the Biotie Therapies Corp.’s pharmaceutical research and d...

$ 1,500.00

Read More

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Industry 2015 Market Research Report

18 Dec 2015  |  Published by:  9Dimen Research
2015 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Autologous Stem Cell and Non-Stem Cell Based Therapies industry, focusing on the main regions (North America, Europ...

$ 2,850.00

Read More

Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry 2015 Market Research Report

20 Nov 2015  |  Published by:  QYResearch
The Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Biomarker Technology Platforms for Cancer Diagnoses and Therapies industry.The report provides a basic overview of the in...

$ 2,800.00

Read More

Global Epigenetic R&D, Therapies and Diagnostics Industry 2015 Market Research Report

19 Nov 2015  |  Published by:  QYResearch
The Global Epigenetic R&D, Therapies and Diagnostics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Epigenetic R&D, Therapies and Diagnostics industry.The report provides a basic overview of the industry including definitions, classifications, a...

$ 2,800.00

Read More

Biotie Therapies Corp. (BTH1V) - Financial and Strategic SWOT Analysis Review

08 Nov 2015  |  Published by:  GlobalData
SummaryBiotie Therapies Corp. (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as Parkinson's disease, Alzheimer's disease and...

$ 300.00

Read More

Vital Therapies, Inc. (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

21 Sep 2015  |  Published by:  GlobalData
SummaryVital Therapies, Inc. (Vital Therapies) is a biotherapeutic company that develops cell-based therapy targeting treatment for liver failure. The company’s clinical trials include VTI-206, VTI-201, VTIC-301, VTI-208, VTI-210 and VTI-212. Its product ELAD is a human-cell-based liver support syst...

$ 250.00

Read More

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

11 Sep 2015  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 250.00

Read More

Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line

01 Sep 2015  |  Published by:  GBI Research
SummaryNon-Small Cell Lung Cancer (NSCLC) is the second most common cancer globally, and the most common cause of cancer-related mortality. Such a p...

$ 4,995.00

Read More

Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook

01 Sep 2015  |  Published by:  GBI Research
Summary"Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook" discusses all gene therapies under the broad criteria of...

$ 2,995.00

Read More

Global Biological Therapies for Cancer Industry 2015 Market Research Report

15 Aug 2015  |  Published by:  QYResearch
The Global Biological Therapies for Cancer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Biological Therapies for Cancer industry.The report provides a basic overview of the industry including definitions, classifications, applications and indu...

$ 2,800.00

Read More
Total 71 records.